These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 115504)

  • 41. A new scaleable method for the purification of botulinum neurotoxin type E.
    Gessler F
    J Biotechnol; 2005 Sep; 119(2):204-11. PubMed ID: 15885835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneities of two components of C2 toxin produced by Clostridium botulinum types C and D.
    Ohishi I; Okada Y
    J Gen Microbiol; 1986 Jan; 132(1):125-31. PubMed ID: 3086490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid method for purification of Clostridium botulinuh type C neurotoxin by High Performance Liquid Chromatography (HPLC ).
    Matsuda M; Ozutsumi K; Pei-Ying D; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-271. PubMed ID: 29464575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COMPARATIVE GEL FILTRATION OF TOXIN PRECURSOR AND TRYPSIN-ACTIVATED TOXIN OF CLOSTRIDIUM BOTULINUM TYPE E.
    SAKAGUCHI G; SAKAGUCHI S; IMAI N
    J Bacteriol; 1964 Feb; 87(2):401-7. PubMed ID: 14151063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding and cytotoxic effects of Clostridium botulinum type A, C1 and E toxins in primary neuron cultures from foetal mouse brains.
    Kurokawa Y; Oguma K; Yokosawa N; Syuto B; Fukatsu R; Yamashita I
    J Gen Microbiol; 1987 Sep; 133(9):2647-57. PubMed ID: 3329217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between the cell-wall peptidoglycan and the progenitor toxin of Clostridium botulinum type C.
    Hyun SH; Sakaguchi G
    Nihon Juigaku Zasshi; 1989 Feb; 51(1):169-76. PubMed ID: 2648051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.
    Sugiyama H; Moberg LJ; Messer SL
    Appl Environ Microbiol; 1977 Apr; 33(4):963-6. PubMed ID: 405926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissociation of Clostridium botulinum type-E-toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochem Biophys Res Commun; 1967 Dec; 29(6):892-7. PubMed ID: 4965663
    [No Abstract]   [Full Text] [Related]  

  • 52. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homogeneity and molecular weight of toxin of Clostridium botulinum type B.
    Boroff DA; Dasgupta BR; Fleck US
    J Bacteriol; 1968 May; 95(5):1738-44. PubMed ID: 4967772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular construction of Clostridium botulinum type F progenitor toxin.
    Ohishi I; Sakaguchi G
    Appl Microbiol; 1975 Apr; 29(4):444-7. PubMed ID: 235882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation and characterization of an esterase-active enzyme from pronase with special reference to activation of Clostridium botulinum type E progenitor toxin.
    Miura T
    Jpn J Med Sci Biol; 1974 Dec; 27(6):285-96. PubMed ID: 4619406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid detection and quantitative estimation of type A botulinum toxin by electroimmunodiffusion.
    Miller CA; Anderson AW
    Infect Immun; 1971 Aug; 4(2):126-9. PubMed ID: 5005291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of heterologous component IIs of botulinum C2 toxin.
    Ohishi I; Hama Y
    Microbiol Immunol; 1992; 36(3):221-9. PubMed ID: 1376392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.
    Iwasaki M; Sakaguchi G
    Infect Immun; 1978 Feb; 19(2):749-51. PubMed ID: 344224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behaviour of toxin released from the cells of Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 1970 Aug; 40(4):925-31. PubMed ID: 4993018
    [No Abstract]   [Full Text] [Related]  

  • 60. Radioimmunoassay for type A toxin of Clostridium botulinum.
    Boroff DA; Chu-Chen G
    Appl Microbiol; 1973 Apr; 25(4):545-9. PubMed ID: 4633477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.